These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30795813)

  • 21. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study.
    Larghi A; Capurso G; Carnuccio A; Ricci R; Alfieri S; Galasso D; Lugli F; Bianchi A; Panzuto F; De Marinis L; Falconi M; Delle Fave G; Doglietto GB; Costamagna G; Rindi G
    Gastrointest Endosc; 2012 Sep; 76(3):570-7. PubMed ID: 22898415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor.
    Grillo F; Albertelli M; Brisigotti MP; Borra T; Boschetti M; Fiocca R; Ferone D; Mastracci L
    Neuroendocrinology; 2016; 103(5):452-9. PubMed ID: 26337010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
    Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
    Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: A 23-year experience at a single institution.
    Christakis I; Qiu W; Hyde SM; Cote GJ; Grubbs EG; Perrier ND; Lee JE
    Surgery; 2018 Jan; 163(1):212-217. PubMed ID: 29122330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs).
    Goto A; Niki T; Terado Y; Fukushima J; Fukayama M
    Histopathology; 2004 Oct; 45(4):384-92. PubMed ID: 15469477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia.
    Wamsteker EJ; Gauger PG; Thompson NW; Scheiman JM
    Gastrointest Endosc; 2003 Oct; 58(4):531-5. PubMed ID: 14520285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis.
    Kurita Y; Hara K; Kuwahara T; Mizuno N; Okuno N; Haba S; Okuno M; Natsume S; Senda Y; Kubota K; Nakajima A; Niwa Y; Shimizu Y
    J Gastroenterol; 2020 May; 55(5):543-552. PubMed ID: 31858231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathologic study with immunohistochemistry of 61 pancreatic endocrine tumors in 16 patients suffering from multiple endocrine neoplasia type I (MEN I). Review of the literature].
    Heymann MF; Moreau A; Chetritt J; Murat A; Leborgne J; Le Neel JC; Visset J; Le Bodic MF
    Ann Pathol; 1996; 16(3):167-73. PubMed ID: 8766173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms.
    Quan L; Liu Y; Cui W; Wang X; Zhang W; Wang Z; Guo C; Lu C; Hu F; Chen X
    Lipids Health Dis; 2022 Jul; 21(1):58. PubMed ID: 35842659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1.
    Bartsch DK; Albers M; Knoop R; Kann PH; Fendrich V; Waldmann J
    Neuroendocrinology; 2013; 98(4):290-8. PubMed ID: 24356648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromogranin a levels in diagnosis, treatment and follow-up of 42 patients with non-functioning pancreatic endocrine tumours.
    Nikou GC; Marinou K; Thomakos P; Papageorgiou D; Sanzanidis V; Nikolaou P; Kosmidis C; Moulakakis A; Mallas E
    Pancreatology; 2008; 8(4-5):510-9. PubMed ID: 18765956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.
    Panzuto F; Cicchese N; Partelli S; Rinzivillo M; Capurso G; Merola E; Manzoni M; Pucci E; Iannicelli E; Pilozzi E; Rossi M; Doglioni C; Falconi M; Delle Fave G
    PLoS One; 2017; 12(6):e0179445. PubMed ID: 28644861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
    Lairmore TC; Chen VY; DeBenedetti MK; Gillanders WE; Norton JA; Doherty GM
    Ann Surg; 2000 Jun; 231(6):909-18. PubMed ID: 10816635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional Growth Velocity and Incidence of Pancreatic Neuroendocrine Neoplasias in Multiple Endocrine Neoplasia Type 1.
    Kann PH; Scheunemann A; Adelmeyer J; Bergmann S; Goebel JN; Bartsch DK; Holzer K; Albers MB; Manoharan J; Scheunemann LM
    Pancreas; 2022 Nov-Dec 01; 51(10):1327-1331. PubMed ID: 37099774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease.
    Singh S; Hallet J; Rowsell C; Law CH
    Eur J Surg Oncol; 2014 Nov; 40(11):1517-22. PubMed ID: 25088936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group.
    Conemans EB; Brosens LAA; Raicu-Ionita GM; Pieterman CRC; de Herder WW; Dekkers OM; Hermus AR; van der Horst-Schrivers AN; Bisschop PH; Havekes B; Drent ML; Timmers HTM; Offerhaus GJ; Valk GD; Vriens MR
    Pancreatology; 2017; 17(5):766-772. PubMed ID: 28811081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodality Imaging of the Pancreatic Neuroendocrine Tumors.
    Singh A; Hines JJ; Friedman B
    Semin Ultrasound CT MR; 2019 Dec; 40(6):469-482. PubMed ID: 31806146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: Correlation between Ki-67 index in cytological samples and clinical behavior.
    Díaz Del Arco C; Esteban López-Jamar JM; Ortega Medina L; Díaz Pérez JÁ; Fernández Aceñero MJ
    Diagn Cytopathol; 2017 Jan; 45(1):29-35. PubMed ID: 27863178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic Neuroendocrine Neoplasias in Multiple Endocrine Neoplasia Type 1 Are Predominantly Located in the Dorsal Anlage: An Endoscopic Ultrasound Study.
    Kann PH; Scheunemann A; Dorzweiler P; Adelmeyer J; Bergmann S; Goebel JN; Mann V; Bartsch DK; Holzer K; Albers MB; Manoharan J; Scheunemann LM
    Pancreas; 2021 Sep; 50(8):1169-1172. PubMed ID: 34714280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.